Reduction of raf kinase inhibitor protein expression is associated with lymph node metastasis in resectable non-small cell lung cancer

Open Respiratory Medicine Journal

Volumn 6, Issue 1, 2012, Pages 135-138

  Yan, Huang ^a   Guoqiang, Lin ^a   Shengxi, Chen ^a   Zhenghao, Deng ^a   Lingjin, Huang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Lymph node metastasis; Non small cell lung cancer; Raf kinase inhibitor protein

Indexed keywords

PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR VOLUME;

EID: 84879151621     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306401206010135     Document Type: Article

References (19)

1. Odabaei G, Chatterjee D, Jazirehi AR, et al. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res 2004; 91: 169-200.
2. Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 2004; 68: 1049-53.
3. Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999; 401: 173-7.
4. Fu Z, Smith PC, Zhang L, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003; 95: 878-89.
5. Fu Z, Kitagawa Y, Shen R, et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 2006; 66: 248-56.
6. Al-Mulla F, Hagan S, Behbehani AI, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 2006; 24: 5672-9.
7. Minoo P, Zlobec I, Baker K, et al. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 2007; 127: 820-7.
8. Hagan S, Al-Mulla F, Mallon E, et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005; 11: 7392-7.
9. Schuierer MM, Bataille F, Hagan S, et al. Reduction in Raf kinase inhibitor protein expression is associated with increased Rasextracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004; 64: 5186-92.
10. Akaishi J, Onda M, Asaka S, et al. Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer. Anticancer Res 2006; 26: 4437-42.
11. Lee HC, Tian B, Sedivy JM, et al. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006; 131: 1208-17.
12. Huerta-Yepez S, Yoon NK, Hernandez-Cueto A, et al. Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. BMC Cancer 2011; 11: 259.
13. The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol 1982; 77: 123-36.
14. Yeung K, Janosch P, McFerran B, et al. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 2000; 20: 3079-85.
15. Yeung KC, Rose DW, Dhillon AS, et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 2001; 21: 7207-17.
16. Kroslak T, Koch T, Kahl E, et al. Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling. J Biol Chem 2001; 276: 39772-8.
17. Eves EM, Shapiro P, Naik K, et al. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 2006; 23: 561-74.
18. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol 2000; 18: 106-15.
19. Fukui T, Mori S, Yokoi K, et al. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol 2006; 1: 120-5.